NCT06522867 Evaluation of Intraocular Pressure Following a Vitreoretinal Surgery Using Goldmann Applanation Tonometry, Icare and Accupen
| NCT ID | NCT06522867 |
| Status | Recruiting |
| Phase | — |
| Sponsor | CHU de Quebec-Universite Laval |
| Condition | Intraocular Pressure |
| Study Type | INTERVENTIONAL |
| Enrollment | 67 participants |
| Start Date | 2024-08-05 |
| Primary Completion | 2025-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 67 participants in total. It began in 2024-08-05 with a primary completion date of 2025-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this prospective controlled study is to measure the reliability of two intraocular pressure (IOP)-measuring instruments in comparison to the gold standard, Goldmann applanation tonometry (GAT) following vitreo-retinal surgery. The main question the current study aims to answer is: are Icare and Accupen as accurate as GAT in measuring IOP one day post eye surgery? Participants in this study will have their IOP measured by the three different instruments one day post-surgery.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 * Received a vitreoretinal surgery Exclusion Criteria: * Corneal dystrophy * Corneal surgery (penetrating keratoplasty, DSAEK/DMEK less than 6 months, radial keratotomy) * Irregular corneal surface * Active corneal ulcer * Active epithelial deficit * Central corneal scarring * A history of scleral buckle
Contact & Investigator
Mathieu Caissie, MD
PRINCIPAL INVESTIGATOR
CHU de Québec - Université Laval
Frequently Asked Questions
Who can join the NCT06522867 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Intraocular Pressure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06522867 currently recruiting?
Yes, NCT06522867 is actively recruiting participants. Contact the research team at cuo.recherche@fmed.ulaval.ca for enrollment information.
Where is the NCT06522867 trial being conducted?
This trial is being conducted at Québec, Canada.
Who is sponsoring the NCT06522867 clinical trial?
NCT06522867 is sponsored by CHU de Quebec-Universite Laval. The principal investigator is Mathieu Caissie, MD at CHU de Québec - Université Laval. The trial plans to enroll 67 participants.